These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7813270)

  • 21. A comparison of triamcinolone acetonide MDI with a built-in tube extender and beclomethasone dipropionate MDI in adult asthmatics.
    Berkowitz R; Rachelefsky G; Harris AG; Chen R
    Chest; 1998 Sep; 114(3):757-65. PubMed ID: 9743163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma.
    Rabe KF; Jörres R; Nowak D; Behr N; Magnussen H
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1436-41. PubMed ID: 8503554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma.
    Maesen FP; Greefhorst LP; Smeets JJ; Wald FD; Cornelissen PJ
    Respiration; 1997; 64(4):273-80. PubMed ID: 9257362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nifedipine in asthma. Dose-related effect on resting bronchial tone.
    Molho M; Gruzman C; Katz I; Lidgi M; Chaniac A
    Chest; 1987 May; 91(5):667-70. PubMed ID: 3552464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bronchial asthma without increased airway reactivity.
    Stănescu DC; Frans A
    Eur J Respir Dis; 1982 Jan; 63(1):5-12. PubMed ID: 7067756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bronchodilatation after inhalation of the antihistamine clemastine.
    Nogrady SG; Hartley JP; Handslip PD; Hurst NP
    Thorax; 1978 Aug; 33(4):479-82. PubMed ID: 694800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a new bronchodilating compound (broxaterol) administered as a pressurized aerosol.
    Robuschi M; Simone P; Vaghi A; Ventresca GP; Bianco S
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):101-4. PubMed ID: 2881897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
    Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and functional responses to salbutamol inhaled via different devices in asthmatic patients with induced bronchoconstriction.
    Lavorini F; Geri P; Luperini M; Maluccio NM; Mariani L; Marmai C; Pistolesi M; Fontana GA
    Br J Clin Pharmacol; 2004 Nov; 58(5):512-20. PubMed ID: 15521899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative bronchodilatory responsiveness attributable to sympathetic and parasympathetic activity in bronchial asthma.
    Jindal SK; Kaur SJ
    Respiration; 1989; 56(1-2):16-21. PubMed ID: 2532383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma.
    Lipworth BJ; Clark RA; Dhillon DP; Brown RA; McDevitt DG
    Br J Clin Pharmacol; 1988 Nov; 26(5):527-33. PubMed ID: 2849969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Forced oscillation technique vs spirometry to assess bronchodilatation in patients with asthma and COPD.
    Zerah F; Lorino AM; Lorino H; Harf A; Macquin-Mavier I
    Chest; 1995 Jul; 108(1):41-7. PubMed ID: 7606989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duration of action of inhaled terbutaline at two different doses and of albuterol in protecting against bronchoconstriction induced by hyperventilation of dry cold air in asthmatic subjects.
    Malo JL; Ghezzo H; Trudeau C; Cartier A; Morris J
    Am Rev Respir Dis; 1989 Sep; 140(3):817-21. PubMed ID: 2782749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The reversibility of airway obstruction to an inhaled beta 2-adrenergic agent is less satisfactory after methacholine testing in asthmatic subjects.
    Malo JL; L'Archevêque J; Ghezzo H; Cartier A
    Chest; 1995 May; 107(5):1370-4. PubMed ID: 7750333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bronchoprotection by salmeterol: cell stabilization or functional antagonism? Comparative effects on histamine- and AMP-induced bronchoconstriction.
    Solèr M; Joos L; Bolliger CT; Elsasser S; Perruchoud AP
    Eur Respir J; 1994 Nov; 7(11):1973-7. PubMed ID: 7875267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bronchodilatory effect of inhaled zardaverine, a phosphodiesterase III and IV inhibitor, in patients with asthma.
    Brunnée T; Engelstätter R; Steinijans VW; Kunkel G
    Eur Respir J; 1992 Sep; 5(8):982-5. PubMed ID: 1426207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of ketotifen on the bronchodilation induced by salbutamol.
    Carpentiere G; Marino S; Castello F; Bonanno CT; Baldanza C
    Respiration; 1988; 54(3):190-2. PubMed ID: 3247518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of inhaled racemic and (R)-albuterol on airway vascular smooth muscle tone in healthy and asthmatic subjects.
    Pereira A; Mendes E; Ferreira T; Wanner A
    Lung; 2003; 181(4):201-11. PubMed ID: 14692560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bronchodilatation with a metered-dose inhaler plus an extension, using tidal breathing vs jet nebulization.
    Gervais A; Bégin P
    Chest; 1987 Nov; 92(5):822-4. PubMed ID: 3665595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
    Cass LM; Gunawardena KA; Macmahon MM; Bye A
    Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.